Angeliq
Angeliq is a medicine authorised by Swissmedic under authorisation number 56275. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 April 2005 and the authorisation is valid without a time limit. ATC code G03FA17 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 56275 |
|---|---|
| Name | Angeliq |
| Full name | Angeliq, Filmtabletten |
| Authorisation holder | Bayer (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G03FA17 |
| First authorisation | 04 April 2005 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Angeliq, Filmtabletten | B | 04 April 2005 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 1 x 28 | Tablette(n) | G03FA17 | 07.08.6. | B |
| 4 | 3 x 28 | Tablette(n) | G03FA17 | 07.08.6. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Angeliq authorised in Switzerland?
Yes. Angeliq is authorised by Swissmedic under authorisation number 56275, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Angeliq have?
Angeliq is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Angeliq?
The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.